These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25213064)

  • 41. Successful clarithromycin desensitization in a multiple macrolide-allergic patient.
    Swamy N; Laurie SA; Ruiz-Huidobro E; Khan DA
    Ann Allergy Asthma Immunol; 2010 Dec; 105(6):489-90. PubMed ID: 21130389
    [No Abstract]   [Full Text] [Related]  

  • 42. Tocilizumab for severe chronic anterior uveitis associated with juvenile idiopathic arthritis in a pediatric patient.
    Tsang AC; Roth J; Gottlieb C
    Ocul Immunol Inflamm; 2014 Apr; 22(2):155-7. PubMed ID: 24377416
    [No Abstract]   [Full Text] [Related]  

  • 43. Rapid desensitization to doxycycline.
    Fernando SL; Hudson BJ
    Ann Allergy Asthma Immunol; 2013 Jul; 111(1):73-4. PubMed ID: 23806469
    [No Abstract]   [Full Text] [Related]  

  • 44. Complete clinical remission with tocilizumab in two infants with systemic juvenile idiopathic arthritis: a case series.
    Maritsi DN; Onoufriou M; Vartzelis G; Eleftheriou D
    Scand J Rheumatol; 2017 Jan; 46(1):75-76. PubMed ID: 27218706
    [No Abstract]   [Full Text] [Related]  

  • 45. Desensitization to chemotherapeutic agents.
    Lieberman P; Castells M
    J Allergy Clin Immunol Pract; 2014; 2(1):116-7. PubMed ID: 24565784
    [No Abstract]   [Full Text] [Related]  

  • 46. [DRUGS DESENSITIZATION].
    Hacard F; Bérard F
    Rev Prat; 2015 Sep; 65(7):986-9. PubMed ID: 26619741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid desensitization to fluconazole (Diflucan).
    Randolph C; Kaplan C; Fraser B
    Ann Allergy Asthma Immunol; 2008 Jun; 100(6):616-7. PubMed ID: 18592829
    [No Abstract]   [Full Text] [Related]  

  • 48. Rapid subcutaneous desensitization for the management of local and systemic hypersensitivity reactions to etanercept and adalimumab in 12 patients.
    Bavbek S; Ataman Ş; Akıncı A; Castells M
    J Allergy Clin Immunol Pract; 2015; 3(4):629-32. PubMed ID: 25725941
    [No Abstract]   [Full Text] [Related]  

  • 49. Successful desensitization with anakinra in a case with immediate hypersensitivity reaction.
    Şoyyiğit S; Kendirlinan R; Aydın O; Çelik GE
    Ann Allergy Asthma Immunol; 2014 Sep; 113(3):325-6. PubMed ID: 25065572
    [No Abstract]   [Full Text] [Related]  

  • 50. Successful rifampin desensitization in a pediatric patient with latent tuberculosis.
    Logsdon S; Ramirez-Avila L; Castells M; Dioun A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):404-5. PubMed ID: 24417546
    [No Abstract]   [Full Text] [Related]  

  • 51. Lenalidomide desensitization for delayed hypersensitivity reactions in 5 patients with multiple myeloma.
    Lee MJ; Wickner P; Fanning L; Schlossman R; Richardson P; Laubach J; Castells M
    Br J Haematol; 2014 Oct; 167(1):127-31. PubMed ID: 24824093
    [No Abstract]   [Full Text] [Related]  

  • 52. Successful Desensitization to Remdesivir Hypersensitivity in a Patient Undergoing Treatment for COVID-19.
    Sim DW; Myoung E; Hoyoung S
    Ann Pharmacother; 2023 Jan; 57(1):110-112. PubMed ID: 35582903
    [No Abstract]   [Full Text] [Related]  

  • 53. Successful fluorescein desensitization.
    Nucera E; Schiavino D; Merendino E; Buonomo A; Roncallo C; Pollastrini E; Lombardo C; De Pasquale T; Patriarca G
    Allergy; 2003 May; 58(5):458. PubMed ID: 12752343
    [No Abstract]   [Full Text] [Related]  

  • 54. Desensitization to Pertuzumab With a Positive Skin Test Result in a Mixed-Phenotype Hypersensitivity Reaction.
    Lemus Calderón JA; Tapia de Pedro G; Marchan Martín E; Guzmán Rodriguez R; Cabañes Higuero MN; Senent Sánchez CJ
    J Investig Allergol Clin Immunol; 2022 Jul; 32(4):320-321. PubMed ID: 34779772
    [No Abstract]   [Full Text] [Related]  

  • 55. [Tocilizumab: experience in a French rheumatological pediatric center].
    Le Stradic C; Galeotti C; Koné-Paut I
    Arch Pediatr; 2014 Dec; 21(12):1299-304. PubMed ID: 25282455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment.
    Inaba Y; Ozawa R; Imagawa T; Mori M; Hara Y; Miyamae T; Aoki C; Saito T; Yokota S
    Ann Rheum Dis; 2011 Sep; 70(9):1693-5. PubMed ID: 21402562
    [No Abstract]   [Full Text] [Related]  

  • 57. Effective desensitization to imiglucerase in a patient with type I Gaucher disease.
    Peroni DG; Pescollderungg L; Piacentini GL; Cassar W; Boner AL
    J Pediatr; 2009 Dec; 155(6):940-1. PubMed ID: 19914435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical characteristics of influenza virus infection in juvenile idiopathic arthritis patients treated with tocilizumab.
    Kawada J; Kitagawa Y; Iwata N; Ito Y
    Mod Rheumatol; 2013 Sep; 23(5):972-6. PubMed ID: 23070362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin 6 inhibition - RA and beyond.
    Woodrick RS; Ruderman EM
    Bull NYU Hosp Jt Dis; 2011; 69(3):225-9. PubMed ID: 22035433
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Desensitization to rifampicin].
    Portu Zapirain J; Aldamiz-Etxebarria San Sebastián M; Fernández Zubiaga M; Jiménez Caudevilla C
    Med Clin (Barc); 1997 Jan; 108(1):35. PubMed ID: 9053576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.